EPK-21001

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameEPK-21001
Drug Alias NameAnti-IL-1 Biologic (TheraKine)EPK-21001
ClassificationBiologics
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsCorneal Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTheraKine Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheraKine Ltd
Active IndicationsN/A
Inactive IndicationsCorneal Injuries

Other Information

ATC CodeN/A
Related LinksN/A